K Hospital
Hanoi, Vietnam
Cancer treatment center in Vietnam
30 Đ. Cầu Bươu, Tân Triều, Thanh Trì, Hà Nội
About K Hospital
"Bệnh viện K Tân Truyền"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
EMD Serono Research & Development Institute, Inc.
1
MetiMedi Pharmaceuticals
1
National Cancer Center, Japan
1
Clinical Trials at K Hospital
During the past decade, K Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)
2017-08-25
2023-01-17
Completed
653
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
2019-09-19
2023-09-17
Active, not recruiting
120
An Observational Study to Evaluate the Real-World Clinical Management and Outcomes of ALK-Positive Advanced NSCLC Participants Treated With Alectinib
2021-05-10
2027-04-09
Recruiting
800
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "K Hospital"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at K Hospital
According to Clinical.Site data, the most researched conditions in "K Hospital" are
"Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Cervical Cancer" (1 trials), "Endometrial Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "K Hospital" in a lesser frequency.
Clinical Trials Intervention Types at K Hospital
Most popular intervention types in "K Hospital" are "Drug" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab Placebo" (1 trials), "Herceptin" (1 trials) and "NGS analysis of ctDNA" (1 trials). Other intervention names were less common.
Clinical Trials Genders at K Hospital
The vast majority of trials in "K Hospital" are
6 trials for "All" genders.
Clinical Trials Status at K Hospital
Currently, there are NaN active trials in "K Hospital".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in K Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in K Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".